Le Lézard
Classified in: Health, Business
Subjects: BUSINESS CONTRACTS, PARTNERSHIPS, HEALTH

Salona Global Announces Exclusive Partnership with Recently Launched U.S. Military Veteran (VA) Focused Distribution Company


NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the ???"Company") ??(TSXV:SGMD), announced today it has executed an exclusive distribution agreement with Veteran Medical Solutions, LLC ("VMS"), a U.S. military veteran owned company that is positioned to sell the Company's Biodex branded equipment.

The Veterans Health Administration of the U.S. Department of Veterans Affairs is the largest integrated heath care system in the United States with over 9 million enrolled.1 Over 760,000 patients were treated by over 2,300 physical therapists, making it the single largest employer of physical therapists in the U.S.2

VMS was launched by Kyle Wilks, a graduate of the U.S. Naval Academy in Annapolis and former Naval Officer. VMS is focused on addressing the numerous physical challenges veterans face upon leaving the service. VMS intends on servicing the growing market demand for physical therapy by U.S. veterans through the sale solely of Biodex equipment. Also joining VMS is Paul Buico, a graduate of the United States Military Academy West Point. Paul has over 25 years of sales, marketing and commercial operations experience in the life science industry with such companies as Bayer and Takeda Abbott Pharmaceuticals.

As a result of becoming a potential customer, Mr. Wilks has resigned from the Board of Directors of the Company.

"We continue to find new channels for our Biodex products," said Mike Seckler, CEO. "Our products hold significant value within the Veterans Affairs heath care system. Kyle and his team of U.S. military veterans are uniquely equipped to ensure the proper support of Biodex products to any VA medical facility requiring them," emphasized Mr. Seckler.

Deirdre Rafferty, MS, ATC from the University of Colorado Anschutz Medical, deeply involved with active military and veterans, shared, "The (Biodex) System 4 allows both researchers and clinicians to better detect musculoskeletal deficiencies within the active duty and veteran community. It provides the necessary information to better address approaches to rehab and ensure a better recovery program."

For more information please contact:?

Mike Seckler
Chief Executive Officer
Tel: 1 (800) 760-6826?
Email: [email protected]

Additional Information

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the ?policies of ??the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this ?release.?

Certain statements contained in this press release constitute "forward-looking information" within the ?meaning of ??the Private Securities Litigation Reform Act of 1995 and applicable Canadian securities ?laws. These statements can ??be identified by the use of forward-looking terminology such as "expects" ??"believes", "estimates", "may", "would", ???"could", ??"should", "potential", ?????"will", "seek", "intend", ??"plan", and "anticipate", and similar expressions as they ??relate ????to the Company, including: VMS becoming a customer of the Company and VMS successfully selling any of the Company's Biodex branded equipment.?

All ?statements ?other than statements of ?historical fact may be forward-looking? information. Such ?statements ??reflect the Company's current views and intentions with respect to future ?events, and ?current information ?available ?to the Company, and are subject to certain risks, ?uncertainties and ?assumptions. The Company cautions that ?the forward-looking statements contained ?herein are qualified by important ?factors that could cause ?actual results to differ materially from those reflected by ?such statements. Such factors ?include but ?are not limited to the ??general business and ??economic ?conditions in the ?regions in ?which the Company ??operates; the ability of the Company to execute on key ??priorities, ?including the ?successful completion ?of ?acquisitions, business? retention, and?? strategic plans and to?? attract, develop ?and retain key ??executives; difficulty ?integrating newly acquired businesses; ??ongoing or new disruptions in the supply ?chain, the ?extent and scope of ?such supply chain disruptions, and the timing or extent of the resolution ?or improvement of ?such disruptions; the ?ability to??? implement business strategies and pursue business ?opportunities; ??disruptions in or ?attacks (including ??cyber-attacks) on the Company's information ?technology, internet, network access or other ??voice ?or data ??communications systems or services; the ?evolution of various types of fraud or other ???criminal behavior to ?which ? ?the Company is exposed; the ?failure of third parties to comply with their obligations to ?? the Company or its ???affiliates; the? impact of ?new and changes to, or application of, current laws and regulations; ?granting of permits ??and licenses ?in a highly regulated business; the ?overall difficult ?????litigation environment, including in the United ???States; increased competition; changes in foreign currency rates; ?increased ????funding ?costs and market ?volatility due ??to market illiquidity and competition for funding; the ?availability of funds ????and ?resources to pursue operations; ??critical ?accounting estimates and changes to accounting standards, ?policies,???? and methods used by the Company; ?the ?occurrence of natural and unnatural?? catastrophic ??events ?and claims ????resulting from such events; as well as ?those ?risk factors discussed or ?referred to ?in ?the ?Company's disclosure ?documents filed with United States ?Securities and ?Exchange Commission ??and ?available at ?www.sec.gov, and with ?the securities regulatory authorities ?in certain ?provinces of ?Canada and ??available at ?www.sedarplus.ca. Should any ?factor affect the Company in an ?unexpected ??manner, or should ??assumptions underlying ?the forward-looking ?information prove incorrect, the actual ??results or ?events may differ ??materially from the results ?or events predicted. ?Any such forward-looking ?information ?is ?expressly qualified in its ??entirety by this cautionary ?statement. Moreover, ?the Company ?does not assume ??responsibility for the accuracy or ??completeness of such ?forward-looking ?information. ?The forward-looking ??information included in this press release ??is made as of the ?date of this press ??release and the Company undertakes ??no obligation to publicly update or revise ??any forward-?looking ?information, ?other than as required by applicable ??law?.?

____________________________________

1 https://www.va.gov/health/
2 https://www.prosthetics.va.gov/PT/



These press releases may also interest you

21 jun 2024
BodyHealth's strawberry flavored PERFECT AMINOtm dietary supplement has...

21 jun 2024
Bristol Myers Squibb  today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for KRAZATI® (adagrasib) in combination with cetuximab as a targeted treatment option for adult patients with KRASG12C-mutated...

21 jun 2024
The Minister of Diversity, Inclusion and Persons with Disabilities, the Honorable Kamal Khera, and the Minister for Women and Gender Equality and Youth, the Honorable Marci Ien, will be in Mississauga to announce investments in mental health support...

21 jun 2024
A Phase 1 study of oral ecnoglutide (1871-LB) showed it to be safe and well tolerated and result in pronounced weight loss (up to -6.76% after 6 weeks of dosing). Improved oral bioavailability enables a 15 to 30 mg daily dose of oral ecnoglutide to...

21 jun 2024
OrsoBio, Inc., a clinical-stage biopharmaceutical company developing treatments for obesity and obesity-associated disorders, today announced new data for liver-targeted mitochondrial protonophore TLC-6740 being presented at the 84th Scientific...

21 jun 2024
Echo Hospice of Orange County, CA, renowned for excellence in hospice care, was honored with a Center of Excellence Award for the Western Region by The Wound Pros: https://www.thewoundpros.com/. This prestigious recognition was presented for Echo...



News published on and distributed by: